
Browse
	Faculties & Departments
	Issue Date
	Author
	Title
	Communities & Collections

Sign on to:
	My DSpace authorized users

Search Results

Search:

for

Results 1-50 of 183.

Sort items by In order | Results/Page Authors/record

Item hits:

Issue Date	Title	Author(s)
2008	Development of infection and inflammation targeting compounds	Laverman, P.; Bleeker-Rovers, C.P.; Corstens, F.H.M.; Boerman, O.C.; Oyen, W.J.G.
2008	Imaging of infectious diseases using [18F] fluorodeoxyglucose PET.	Bleeker-Rovers, C.P.; Vos, F.J.; Corstens, F.H.M.; Oyen, W.J.G.
2008	Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer.	Geus-Oei, L.F. de; Laarhoven, H.W.M. van; Visser, E.P.; Hermsen, R.; Hoorn, B.A. van; Kamm, Y.J.L.; Krabbe, P.F.M.; Corstens, F.H.M.; Punt, C.J.A.; Oyen, W.J.G.
2008	Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.	Zuijdwijk, M.D.; Vogel, W.V.; Corstens, F.H.M.; Oyen, W.J.G.
2008	Comparison of tumor volumes derived from glucose metabolic rate maps and SUV maps in dynamic 18F-FDG PET.	Visser, E.P.; Philippens, M.E.P.; Kienhorst, L.; Kaanders, J.H.A.M.; Corstens, F.H.M.; Geus-Oei, L.F. de; Oyen, W.J.G.
2007	Radionuclide therapy of cancer with radiolabeled antibodies.	Boerman, O.C.; Koppe, M.J.; Postema, E.J.; Corstens, F.H.M.; Oyen, W.J.G.
2007	Development and application of peptide-based radiopharmaceuticals.	Dijkgraaf, I.; Boerman, O.C.; Oyen, W.J.G.; Corstens, F.H.M.; Gotthardt, M.
2007	Multi-modality nuclear medicine imaging : artefacts, pitfalls and recommendations	Dalen, J.A. van; Vogel, W.V.; Corstens, F.H.M.; Oyen, W.J.G.
2007	Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes.	Dijkgraaf, I.; Rijnders, A.Y.; Soede, A.C.; Dechesne, A.C.; Esse, G.W. van; Brouwer, A.J.; Corstens, F.H.M.; Boerman, O.C.; Rijkers, D.T.; Liskamp, R.M.
2007	Predictive and prognostic value of FDG-PET in nonsmall-cell lung cancer: a systematic review.	Geus-Oei, L.F. de; Heijden, H.F.M. van der; Corstens, F.H.M.; Oyen, W.J.G.
2007	Scintigraphy with 99mTc-labeled heat-altered erythrocytes in diagnosing hyposplenia: prospective comparison to 99mTc-labeled colloids and colour-coded duplex ultrasonography.	Gotthardt, M.; Broker, S.; Schlieck, A.; Bauhofer, A.; Herbst, B.; Behe, M.; Corstens, F.H.M.; Behr, T.M.; Gorg, C.
2007	Impact of Ge-68/Ga-68-based versus CT-based attenuation correction on PET.	Dalen, J.A. van; Visser, E.P.; Vogel, W.V.; Corstens, F.H.M.; Oyen, W.J.G.
2007	Improved targeting of the alpha(v)beta (3) integrin by multimerisation of RGD peptides.	Dijkgraaf, I.; Kruijtzer, J.A.; Liu, S.; Soede, A.C.; Oyen, W.J.G.; Corstens, F.H.M.; Liskamp, R.M.; Boerman, O.C.
2007	Software package for integrated data processing for internal dose assessment in nuclear medicine (SPRIND).	Visser, E. de; Postema, E.J.; Boerman, O.C.; Visschers, J.; Oyen, W.J.G.; Corstens, F.H.M.
2007	PET imaging of infection with a HYNIC-conjugated LTB4 antagonist labeled with F-18 via hydrazone formation.	Rennen, H.J.J.M.; Laverman, P.; Eerd-Vismale, J.E.M. van; Oyen, W.J.G.; Corstens, F.H.M.; Boerman, O.C.
2007	Preclinical evaluation of technetium 99m-labeled P1827DS for infection imaging and comparison with technetium 99m IL-8.	Krause, S.; Rennen, H.J.J.M.; Boerman, O.C.; Baumann, S.; Cyr, J.E.; Manchanda, R.; Lister-James, J.; Corstens, F.H.M.; Dinkelborg, L.M.
2007	A prospective multi-centre study of the value of FDG-PET as part of a structured diagnostic protocol in patients with fever of unknown origin.	Bleeker-Rovers, C.P.; Vos, F.J.; Mudde, A.H.; Dofferhoff, A.S.M.; Geus-Oei, L.F. de; Rijnders, A.J.; Krabbe, P.F.M.; Corstens, F.H.M.; Meer, J.W.M. van der; Oyen, W.J.G.
2007	Alpha v beta 3 integrin-targeting of intraperitoneally growing tumors with a radiolabeled RGD peptide.	Dijkgraaf, I.; Kruijtzer, J.A.; Frielink, C.; Corstens, F.H.M.; Oyen, W.J.G.; Liskamp, R.M.; Boerman, O.C.
2007	Evaluation of image registration in PET/CT of the liver and recommendations for optimized imaging.	Vogel, W.V.; Dalen, J.A. van; Wiering, B.; Huisman, H.J.; Corstens, F.H.M.; Ruers, T.J.M.; Oyen, W.J.G.
2007	99mTc-labeled interleukin 8 for the scintigraphic detection of infection and inflammation: first clinical evaluation.	Bleeker-Rovers, C.P.; Rennen, H.J.J.M.; Boerman, O.C.; Wymenga, A.B.; Visser, E.P.; Bakker, J.H.; Meer, J.W.M. van der; Corstens, F.H.M.; Oyen, W.J.G.
2007	Effects of linker variation on the in vitro and in vivo characteristics of an 111In-labeled RGD peptide.	Dijkgraaf, I.; Liu, S.; Kruijtzer, J.A.; Soede, A.C.; Oyen, W.J.G.; Liskamp, R.M.; Corstens, F.H.M.; Boerman, O.C.
2007	Chemotherapy response evaluation with 18F-FDG PET in patients with non-small cell lung cancer.	Geus-Oei, L.F. de; Heijden, H.F.M. van der; Visser, E.P.; Hermsen, R.; Hoorn, B.A. van; Timmer-Bonte, J.N.H.; Willemsen, A.T.M.; Pruim, J.; Corstens, F.H.M.; Krabbe, P.F.M.; Oyen, W.J.G.
2006	Targeting of biliary cancer with radiolabeled chimeric monoclonal antibody CG250.	Hendrickx, B.W.; Punt, C.J.A.; Boerman, O.C.; Postema, E.J.; Oosterwijk, E.; Mavridu, A.; Corstens, F.H.M.; Oyen, W.J.G.
2006	Reply to LTE: Inhibition of Kidney Uptake of Radiolabeled Somatostatin Analogs: Amino Acids or Gelofusine?	Eerd-Vismale, J.E.M. van; Vegt, E.; Wetzels, J.F.M.; Russel, F.G.M.; Masereeuw, R.; Corstens, F.H.M.; Boerman, O.C.; Oyen, W.J.G.
2006	Reply: inhibition of kidney uptake of radiolabeled somatostatin analogs: aminoacids or gelofusine?	Eerd, J.J. van; Vegt, E.; Wetzels, J.F.M.; Russel, F.G.M.; Masereeuw, R.; Corstens, F.H.M.; Boerman, O.C.; Oyen, W.J.G.
2006	Iron absorption during epoetin alfa therapy for chemotherapy-associated anaemia.	Savonije, J.H.; Groeningen, C.J. van; Broek, W.J.A.A. van den; Rentinck, M.E.; Corstens, F.H.M.; Gundy, C.; Giaccone, G.; Marx, J.J.M.
2006	FDG-PET for imaging of non-osseous infection and inflammation.	Vos, F.J.; Bleeker-Rovers, C.P.; Corstens, F.H.M.; Kullberg, B.J.; Oyen, W.J.G.
2006	Effects of hyperoxygenation on FDG-uptake in head-and-neck cancer.	Geus-Oei, L.F. de; Kaanders, J.H.A.M.; Pop, L.A.M.; Corstens, F.H.M.; Oyen, W.J.G.
2006	Comparison of image-derived and arterial input functions for estimating the rate of glucose metabolism in therapy-monitoring 18F-FDG PET studies.	Geus-Oei, L.F. de; Visser, E.P.; Krabbe, P.F.M.; Hoorn, B.A. van; Koenders, E.B.; Willemsen, A.T.M.; Pruim, J.; Corstens, F.H.M.; Oyen, W.J.G.
2006	FDG-PET in colorectal cancer.	Geus-Oei, L.F. de; Ruers, T.J.M.; Punt, C.J.A.; Leer, J.W.H.; Corstens, F.H.M.; Oyen, W.J.G.
2006	What is the best pre-therapeutic dosimetry for successful radioiodine therapy of multifocal autonomy?	Gotthardt, M.; Rubner, C.; Bauhofer, A.; Berce, F.; Oyen, W.J.G.; Goecke, J.; Pfestroff, A.; Schlieck, A.; Corstens, F.H.M.; Behe, M.; Behr, T.M.
2006	Decrease of (99m)Tc-uptake in autonomous thyroid tissue in Germany since the 1970s. Clinical implications for radioiodine therapy.	Gotthardt, M.; Stubinger, M.; Pansegrau, J.; Buchwald, B.; Goecke, J.; Pfestroff, A.; Corstens, F.H.M.; Behr, T.M.
2006	Correction of an image size difference between positron emission tomography (PET) and computed tomography (CT) improves image fusion of dedicated PET and CT.	Vogel, W.V.; Dalen, J.A. van; Schinagl, D.A.X.; Kaanders, J.H.A.M.; Huisman, H.J.; Corstens, F.H.M.; Oyen, W.J.G.
2006	Renal uptake of radiolabeled octreotide in human subjects is efficiently inhibited by succinylated gelatin.	Vegt, E.; Wetzels, J.F.M.; Russel, F.G.M.; Masereeuw, R.; Boerman, O.C.; Eerd-Vismale, J.E.M. van; Corstens, F.H.M.; Oyen, W.J.G.
2006	Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats.	Eerd-Vismale, J.E.M. van; Vegt, E.; Wetzels, J.F.M.; Russel, F.G.M.; Masereeuw, R.; Corstens, F.H.M.; Oyen, W.J.G.; Boerman, O.C.
2006	Scintigraphic imaging of P-glycoprotein expression with a radiolabelled antibody.	Eerd-Vismale, J.E.M. van; Geus-Oei, L.F. de; Oyen, W.J.G.; Corstens, F.H.M.; Boerman, O.C.
2006	Synthesis and biological evaluation of potent alphavbeta3-integrin receptor antagonists.	Dijkgraaf, I.; Kruijtzer, J.A.; Frielink, C.; Soede, A.C.; Hilbers, H.W.; Oyen, W.J.G.; Corstens, F.H.M.; Liskamp, R.M.; Boerman, O.C.
2006	18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.	Geus-Oei, L.F. de; Pieters, G.F.F.M.; Bonenkamp, J.J.; Mudde, A.H.; Bleeker-Rovers, C.P.; Corstens, F.H.M.; Oyen, W.J.G.
2005	Discriminating infection from sterile inflammation: can radiolabelled antibiotics solve the problem?	Oyen, W.J.G.; Corstens, F.H.M.; Boerman, O.C.
2005	Diagnosis of Candida lung abscesses by 18F-fluorodeoxyglucose positron emission tomography.	Bleeker-Rovers, C.P.; Warris, A.; Drenth, J.P.H.; Corstens, F.H.M.; Oyen, W.J.G.; Kullberg, B.J.
2005	Colorectal cancer: the role of PET/CT in recurrence.	Vogel, W.V.; Wiering, B.; Corstens, F.H.M.; Ruers, T.J.M.; Oyen, W.J.G.
2005	Synthesis of leukotriene B4 antagonists labeled with In-111 or Tc-99m to image infectious and inflammatory foci.	Broekema, M.; Eerd, J.J. van; Oyen, W.J.G.; Corstens, F.H.M.; Liskamp, R.M.; Boerman, O.C.; Harris, T.D.
2005	Influence of blood glucose level, age and fasting period on non-pathological FDG uptake in heart and gut.	Groot, M. de; Meeuwis, A.P.W.; Kok, P.J.; Corstens, F.H.M.; Oyen, W.J.G.
2005	18F-FDG PET in Detecting Metastatic Infectious Disease.	Bleeker-Rovers, C.P.; Vos, F.J.; Wanten, G.J.A.; Meer, J.W.M. van der; Corstens, F.H.M.; Kullberg, B.J.; Oyen, W.J.G.
2005	Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma.	Brouwers, A.H.; Mulders, P.F.A.; Mulder, P.H.M. de; Broek, W.J.M. van den; Buijs, W.C.A.M.; Mala, C.; Joosten, F.B.M.; Oosterwijk, E.; Boerman, O.C.; Corstens, F.H.M.; Oyen, W.J.G.
2005	Biodistribution and imaging of FDG in rats with LS174T carcinoma xenografts and focal Escherichia coli infection.	Kok, P.J.; Eerd-Vismale, J.E.M. van; Boerman, O.C.; Corstens, F.H.M.; Oyen, W.J.G.
2005	Imaging of infection and inflammation with an improved 99mTc-labeled LTB4 antagonist.	Eerd-Vismale, J.E.M. van; Broekema, M.; Harris, T.D.; Edwards, D.S.; Oyen, W.J.G.; Corstens, F.H.M.; Boerman, O.C.
2005	Comparison of IgG and F(ab')2 fragments of bispecific anti-RCCxanti-DTIn-1 antibody for pretargeting purposes.	Schaijk, F.G. van; Boerman, O.C.; Soede, A.C.; McBride, W.J.; Goldenberg, D.M.; Corstens, F.H.M.; Oosterwijk, E.
2005	Residualizing iodine markedly improved tumor targeting using bispecific antibody-based pretargeting.	Schaijk, F.G. van; Broekema, M.; Oosterwijk, E.; Eerd-Vismale, J.E.M. van; McBride, B.J.; Goldenberg, D.M.; Corstens, F.H.M.; Boerman, O.C.
2005	Pretargeting with bispecific anti-renal cell carcinoma x anti-DTPA(In) antibody in 3 RCC models.	Schaijk, F.G. van; Oosterwijk, E.; Molkenboer-Kuenen, J.D.M.; Soede, A.C.; McBride, B.J.; Goldenberg, D.M.; Oyen, W.J.G.; Corstens, F.H.M.; Boerman, O.C.

1 2 3 4 next